153 related articles for article (PubMed ID: 38268740)
1. Late thrombosis of Gore Cardioform septal occluder device in a patient with history of patent foramen ovale closure.
Khalil MH; Haider M; Mehta S
Radiol Case Rep; 2024 Apr; 19(4):1386-1390. PubMed ID: 38268740
[TBL] [Abstract][Full Text] [Related]
2. Left atrial disc device thrombosis after atrial defect closure with the Gore® Cardioform septal occluder: A case series.
Kramer P; Opgen-Rhein B; Berger F; Nordmeyer J
Catheter Cardiovasc Interv; 2023 Aug; 102(2):359-363. PubMed ID: 37313625
[TBL] [Abstract][Full Text] [Related]
3. A Comparison Between Gore Cardioform and Amplatzer Septal Occluder for Percutaneous Closure of Patent Foramen Ovale Associated With Atrial Septal Aneurysm: Clinical and Echocardiographic Outcomes.
Musto C; Cifarelli A; Dipasquale F; Chin D; Nazzaro MS; Stio RE; Pennacchi M; De Felice F
J Invasive Cardiol; 2021 Nov; 33(11):E857-E862. PubMed ID: 34653958
[TBL] [Abstract][Full Text] [Related]
4. Transcatheter Closure of Atrial Septal Defect: A Review of Currently Used Devices.
Shrivastava S; Shrivastava S; Allu SVV; Schmidt P
Cureus; 2023 Jun; 15(6):e40132. PubMed ID: 37425612
[TBL] [Abstract][Full Text] [Related]
5. Patent foramen ovale closure with GORE HELEX or CARDIOFORM Septal Occluder vs. antiplatelet therapy for reduction of recurrent stroke or new brain infarct in patients with prior cryptogenic stroke: Design of the randomized Gore REDUCE Clinical Study.
Kasner SE; Thomassen L; Søndergaard L; Rhodes JF; Larsen CC; Jacobson J
Int J Stroke; 2017 Dec; 12(9):998-1004. PubMed ID: 29090661
[TBL] [Abstract][Full Text] [Related]
6. Cryptogenic Stroke Caused by a Newly Diagnosed Patent Foramen Ovale in a Healthy Young Adult.
Ukponmwan EU; Banga S; Kim AG; Qintar M; Abela G
Cureus; 2023 Oct; 15(10):e46895. PubMed ID: 37954786
[TBL] [Abstract][Full Text] [Related]
7. Comparison of residual shunt rate and complications across 6 different closure devices for patent foramen ovale.
Gevorgyan Fleming R; Kumar P; West B; Noureddin N; Rusheen J; Aboulhosn J; Tobis JM
Catheter Cardiovasc Interv; 2020 Feb; 95(3):365-372. PubMed ID: 31654558
[TBL] [Abstract][Full Text] [Related]
8. The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke.
Wiktor DM; Carroll JD
Circ Cardiovasc Interv; 2018 Mar; 11(3):e004152. PubMed ID: 29870380
[TBL] [Abstract][Full Text] [Related]
9. Patent foramen ovale with right atrial septal pouch.
Kijima Y; Bokhoor P; Tobis JM
Catheter Cardiovasc Interv; 2017 Apr; 89(5):E169-E171. PubMed ID: 26711371
[TBL] [Abstract][Full Text] [Related]
10. Initial use of the new GORE(®) septal occluder in patent foramen ovale closure: implantation and preliminary results.
MacDonald ST; Daniels MJ; Ormerod OJ
Catheter Cardiovasc Interv; 2013 Mar; 81(4):660-5. PubMed ID: 23436483
[TBL] [Abstract][Full Text] [Related]
11. Iatrogenic erosion of the septum primum resulting in an atrial septal defect with left-to-right shunt: a rare pitfall of patent foramen ovale percutaneous closure.
Scacciatella P; Biava LM; Marra S
Catheter Cardiovasc Interv; 2014 Sep; 84(3):494-6. PubMed ID: 24399577
[TBL] [Abstract][Full Text] [Related]
12. Embolization of patent foramen ovale closure devices: incidence, role of imaging in identification, potential causes, and management.
Goel SS; Aksoy O; Tuzcu EM; Krasuski RA; Kapadia SR
Tex Heart Inst J; 2013; 40(4):439-44. PubMed ID: 24082375
[TBL] [Abstract][Full Text] [Related]
13. Closure of patent foramen ovale defects using GORE® CARDIOFORM septal occluder: Results from a prospective European multicenter study.
Hardt SE; Eicken A; Berger F; Schubert S; Carminati M; Butera G; Grohmann J; Höhn R; Nielsen-Kudsk JE; Hildick-Smith D; Settergren M; Thomson JD; Geis N; Søndergaard L
Catheter Cardiovasc Interv; 2017 Nov; 90(5):824-829. PubMed ID: 28296023
[TBL] [Abstract][Full Text] [Related]
14. Experimental study of the bilateral asymmetric single-rivet occluder device for transcatheter patent foramen ovale closure with reserved interatrial septal puncture area.
Wei Y; Su Y; Cao S; He Z; Wang R; Qin X; Feng Y; Yang C; Jiang H
Front Cardiovasc Med; 2023; 10():1301412. PubMed ID: 38250032
[TBL] [Abstract][Full Text] [Related]
15. Transseptal puncture to facilitate device closure of "long-tunnel" patent foramen ovale.
Thompson AJ; Hagler DJ; Taggart NW
Catheter Cardiovasc Interv; 2015 May; 85(6):1053-7. PubMed ID: 25380406
[TBL] [Abstract][Full Text] [Related]
16. Systemic Allergic Contact Dermatitis Due to a GORE CARDIOFORM Septal Occluder Device: A Case Report and Literature Review.
Resor CD; Goldminz AM; Shekar P; Padera R; O'Gara PT; Shah PB
JACC Case Rep; 2020 Oct; 2(12):1867-1871. PubMed ID: 34317069
[TBL] [Abstract][Full Text] [Related]
17. Intermediate and long-term results of transcatheter closure of patent foramen ovale using the amplatzer patent foramen ovale occluder: one case of pulmonary embolism irrespective of patent foramen ovale closure.
Yoon JH; Kim JS; Lee DH; Shim EJ; Lee SY; Min KS; Cho DJ; Lee HR
Korean Circ J; 2011 Jul; 41(7):356-62. PubMed ID: 21860636
[TBL] [Abstract][Full Text] [Related]
18. Clinical Experience of Percutaneous Patent Foramen Ovale Closure Using the Amplatzer PFO Occluder in Japanese Patients to Prevent the Recurrence of Cryptogenic Stroke.
Takafuji H; Obunai K; Makihara Y; Kato N; Watanabe H
Intern Med; 2021 Nov; 60(21):3385-3390. PubMed ID: 34024855
[TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation after closure of patent foramen ovale in the REDUCE clinical study.
Andersen A; Matzen KL; Andersen G; Settergren M; Sjostrand C; Iversen HK; Roine RO; Hildick-Smith D; Spence JD; Rhodes JF; Kasner SE; Sondergaard L; Nielsen-Kudsk JE
Catheter Cardiovasc Interv; 2022 Apr; 99(5):1551-1557. PubMed ID: 34773685
[TBL] [Abstract][Full Text] [Related]
20. The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale.
Aral M; Mullen M
Catheter Cardiovasc Interv; 2015 May; 85(6):1058-65. PubMed ID: 25413379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
